0001209191-23-004044.txt : 20230119
0001209191-23-004044.hdr.sgml : 20230119
20230119170210
ACCESSION NUMBER: 0001209191-23-004044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230117
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrnes Michael
CENTRAL INDEX KEY: 0001619893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 23538061
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPEUTICS, INC.
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-17
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001619893
Byrnes Michael
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
0.47
2023-01-17
4
A
0
500000
0.00
A
2033-01-16
Common Stock
500000
500000
D
1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 17, 2023 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.
/s/ Michael Byrnes
2023-01-19